Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation

Total article views   Abstract views HTML views PDF downloads Totals
11,982 Dovepress* 8,020 2,688+ 1,304 10,708
PubMed Central* 0 1,274 447 1,274
Totals 8,020 3,962 1,751 11,982
*Since 16 April 2018
+Since July 2016

View citations on PubMed Central and Google Scholar